These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 6429708)
1. Differential effects of apomorphine in 6-hydroxydopamine-treated and aged rats. Schechter MD; Concannon JT Psychopharmacology (Berl); 1984; 83(1):99-103. PubMed ID: 6429708 [TBL] [Abstract][Full Text] [Related]
2. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats. Breese GR; Napier TC; Mueller RA J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987 [TBL] [Abstract][Full Text] [Related]
3. Effects of selective dopamine receptor agonists in rats trained to discriminate apomorphine from saline. Woolverton WL; Kamien JB; Goldberg LI Pharmacol Biochem Behav; 1985 Apr; 22(4):577-81. PubMed ID: 3873077 [TBL] [Abstract][Full Text] [Related]
4. Effects of central dopamine depletion on the d-amphetamine discriminative stimulus in rats. Woolverton WL; Cervo L Psychopharmacology (Berl); 1986; 88(2):196-200. PubMed ID: 3006111 [TBL] [Abstract][Full Text] [Related]
5. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens. Robbins TW; Roberts DC; Koob GF J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587 [TBL] [Abstract][Full Text] [Related]
7. CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats. Weiss F; Ettenberg A; Koob GF Psychopharmacology (Berl); 1989; 99(3):409-15. PubMed ID: 2574480 [TBL] [Abstract][Full Text] [Related]
8. Effect of chronic apomorphine on the development of denervation supersensitivity. Robin M; Forler C; Palfreyman MG Pharmacol Biochem Behav; 1985 Apr; 22(4):547-51. PubMed ID: 3921992 [TBL] [Abstract][Full Text] [Related]
9. Comparative effects of infusions of 6-hydroxydopamine into nucleus accumbens and anterolateral hypothalamus induced by 6-hydroxydopamine on the response to dopamine agonists, body weight, locomotor activity and measures of exploration in the rat. Winn P; Robbins TW Neuropharmacology; 1985 Jan; 24(1):25-31. PubMed ID: 3920545 [TBL] [Abstract][Full Text] [Related]
10. Effects of apomorphine on escape performance and activity in developing rat pups treated with 6-hydroxydopamine (6-OHDA). Lipton SV; McGough JP; Shaywitz BA Pharmacol Biochem Behav; 1980 Sep; 13(3):371-7. PubMed ID: 7191569 [TBL] [Abstract][Full Text] [Related]
11. Effects of apomorphine on appetitive conditioning in 6-hydroxydopamine treated rat pups. Weldon DA; Wool RS; Teicher MH; Shaywitz BA; Cohen DJ; Anderson GM Pharmacol Biochem Behav; 1982 Dec; 17(6):1281-4. PubMed ID: 6819587 [TBL] [Abstract][Full Text] [Related]
12. Haloperidol-induced supersensitivity to the discrimination of apomorphine. Schechter MD Eur J Pharmacol; 1981 Sep; 74(4):343-6. PubMed ID: 7297600 [TBL] [Abstract][Full Text] [Related]
13. Apomorphine-induced inhibition of neostriatal activity is enhanced by lesions induced by 6-hydroxydopamine but not by long-term administration of amphetamine. Alloway KD; Rebec GV Neuropharmacology; 1984 Sep; 23(9):1033-9. PubMed ID: 6096755 [TBL] [Abstract][Full Text] [Related]
14. Effects of neonatal and adult 6-hydroxydopamine treatment on random-interval behavior. Levine TE; Erinoff L; Dregits DP; Seiden LS Pharmacol Biochem Behav; 1980 Feb; 12(2):281-5. PubMed ID: 7375490 [TBL] [Abstract][Full Text] [Related]
15. Supersensitivity of presynaptic receptors involved in the dopaminergic control of striatal high affinity glutamate uptake after 6-hydroxydopamine lesion of nigrostriatal dopaminergic neurons. Kerkerian L; Nieoullon A Exp Brain Res; 1988; 69(2):424-30. PubMed ID: 2894320 [TBL] [Abstract][Full Text] [Related]
16. Effect of 6-OHDA injected into the locus coeruleus on apomorphine-induced aggression. PuciĆowski O; Kozak W; Valzelli L Pharmacol Biochem Behav; 1986 Mar; 24(3):773-5. PubMed ID: 2422669 [TBL] [Abstract][Full Text] [Related]
17. Heterogeneous rotational responsiveness in 6-hydroxydopamine-denervated rats: pharmacological and neurochemical characterization. Liebman JM; Gerber R; Hall NR; Altar CA Psychopharmacology (Berl); 1988; 96(4):477-83. PubMed ID: 3149769 [TBL] [Abstract][Full Text] [Related]
18. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306 [TBL] [Abstract][Full Text] [Related]
19. Behavioural supersensitivity to apomorphine following cerebral dopaminergic denervation by 6-hydroxydopamine. Nahorski SR Psychopharmacologia; 1975 May; 42(2):159-62. PubMed ID: 1172249 [TBL] [Abstract][Full Text] [Related]
20. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT; White FJ Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]